Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 164.28% | 7.20% | -365.97% | -63.70% | -149.50% |
| Total Depreciation and Amortization | 29.32% | 9.33% | 12.97% | 1.09% | -2.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.38% | -7.70% | 480.59% | 88.47% | 4,778.60% |
| Change in Net Operating Assets | -423.69% | 2,824.24% | -101.82% | 190.88% | -66.75% |
| Cash from Operations | -49.88% | 13.37% | -55.28% | 40.40% | 4.87% |
| Capital Expenditure | 73.02% | -21.15% | 78.51% | -62.42% | -50.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 73.02% | -21.15% | 78.51% | -62.42% | -50.51% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 309.23% | 6.99% | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,249.61% | -2.58% | -95.60% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 468.91% | 14.24% | -158.19% | 241.68% | -419.03% |